SQQQ

Down 3.43% to 36.04, bleeding out right against the 52-week low of 35.74 — 1st percentile of range, -45.9% YTD. An inverse 3x in an uptrend is a slow-motion exsanguination machine. With benign CPI and PPI defusing the September hike scare, the only short-Nasdaq scripts left are an AI-earnings landmine or data turning hawkish again. Useful solely as short-dated event insurance — and insurance means paying premium: decay plus trend headwind charges you rent every day you hold it.

The 3x inverse Nasdaq fund fell 2.15% to 37.32, hovering just above its 52-week low of 35.80. RSI at 41.8 is weak and price is pinned below the 20-day (41.57) and 50-day (40.21) SMAs. The tame CPI print undercuts the short-tech thesis for now; down 44% year to date, this inverse 3x product bleeds value relentlessly over time — unsuitable to hold, and best viewed strictly as an ultra-short-term hedge.

Up 1.09% with RSI at 43.5. A 3x Nasdaq short sitting 35.6% below its 200-day — a standing illustration of what holding inverse leverage long-term costs. Intraday hedging only.

Up 0.88% with RSI at 42.4. A 3x Nasdaq short sitting just 5.4% off its 52-week low — with the index printing new highs, inverse leverage suffers the harshest time decay of all.

Down 3.36% as the 3x mirror of the Nasdaq's advance, with RSI at 41.6 after declines of 12.9% for the week and 9.2% for the month; shorting the Nasdaq is punishing to hold while indices keep setting records.

Up 1.07% as the 3x mirror of the Nasdaq's small decline, with RSI at 43.9 while the week is still down 16.8%. Even on a down day for the index its weekly return stays negative — inverse leverage is punishing to hold in a choppy tape.

3x short the Nasdaq, up 2.8% on the tech pullback — a hedging tool only. The Nasdaq trend is still up and inverse leverage decays over time; not for holding.

Down 10.07%, the 3x mirror of the Nasdaq's surge, off 19.7% on the week with RSI at 40.7 below the 50-day at $40.35. The cost of shorting the Nasdaq compounds in a one-way tape, making inverse leverage punishing to hold.

Down 5.26% on 2.57x volume, the mirror of the Nasdaq's surge. A 9.3% monthly gain shows the short worked earlier, but today's high-volume decline signals the turn — inverse leverage carries punishing holding costs.

Up 2.85% as the inverse 3x of the Nasdaq's decline, RSI 63.1. Yet price sits ~24% below its 200-day, a direct illustration of structural decay — intraday hedging only, never a hold

A +5.7% hedging cameo — tactical event-week protection only; decay forbids holding

Crushed -5.6% by the rebound — inverse leverage is an intraday hedge, not a worldview

Up 4.65% to $42.79, +11.2% on the week — the Nasdaq hedge finally paid. But it's a fire extinguisher, not a fireplace: one rally candle torches a week of gains

Up 5.0% to $40.89, the bear week's trophy — though inverse-leverage wins only ever belong to day traders

Up 0.8% to $38.94, small win on a small Nasdaq dip — still strictly an intraday hedging tool

Up 5.7% to $39.95 on the bears' day — inverse leverage is a day-hedge only; holding overnight is working for the decay

Down 0.8%, the inverse Nasdaq bleeding on, 3% off 52-week lows — hedging demand found no case this week

Down 4.9%, the inverse Nasdaq badly wounded on tech-rally day; time to turn the page on the hedge

Down 0.7% as the inverse Nasdaq bled on chip-bounce day; use the hedge and leave — don't develop feelings overnight

+4.2% the chip-rout hedge; an intraday tool — no overnight holds before a confirmed reversal

-4.2% 3x Nasdaq short; an intraday hedge in a rebound, don't linger before a reversal

3x Nasdaq short +5.5% — an intraday hedge for the chip pullback; don't linger without a confirmed reversal

Hedging tool only (e.g., covering through earnings weeks); holding it in an uptrend is slow bleed